#Pharma #Santé ailleurs UK cost agency turns down Sanofi bowel #cancer drug | Reuters http://t.co/0lsd5rIiIi cc @mtu31
June 21, 2013
Publicité
UK cost agency turns down Sanofi bowel cancer drug
The National Institute for Health and Clinical Excellence (NICE) said the medicine was clinically effective but it could not be considered a cost-effective use of National Health Service resources - even though Sanofi offered a discount. The draft decision, which is now open to consultation, will be a disappointment for the French drugmaker and its U.S.